논문 목록
6건 · 최신순-
Trial Design for Mixed Urinary Incontinence: Midurethral Sling Versus Botulinum Toxin A.
[IMPORTANCE] Mixed urinary incontinence (MUI) is common and can be challenging to manage. [OBJECTIVES] We present the protocol design and rationale of a trial comparing the efficacy of 2 procedures for the treatment of women with MUI refra…
-
Predicting outcomes after intradetrusor onabotulinumtoxina for non-neurogenic urgency incontinence in women.
[AIMS] Develop models to predict outcomes after intradetrusor injection of 100 or 200 units of onabotulinumtoxinA in women with non-neurogenic urgency urinary incontinence (UUI). [METHODS] Models were developed using 307 women from two ran…
-
Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial.
[PURPOSE] Sacral neuromodulation and intradetrusor onabotulinumtoxinA injection are therapies for refractory urgency urinary incontinence. Sacral neuromodulation involves surgical implantation of a device that can last 4 to 6 years while on…
-
Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function.
[BACKGROUND] Women with refractory urgency urinary incontinence can be treated with onabotulinumtoxinA or sacral neuromodulation. Little data exists on the comparative effects of treatment of refractory urgency urinary incontinence on other…
-
Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
[BACKGROUND] Urgency urinary incontinence (UUI) is a chronic condition for which sacral neuromodulation (SNM) (InterStim/Medtronic) and onabotulinumtoxinA (BTX) (BotoxA/Allergan) are utilized. These therapies have not been compared over ext…
-
Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.
[PURPOSE] We sought to identify clinical and demographic characteristics associated with treatment response and satisfaction in women undergoing onabotulinumtoxinA and sacral neuromodulation therapies. [MATERIALS AND METHODS] We analyzed d…